PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsPrilocaine
Citanest, Fortacin(prilocaine)
/ Prilocaine, Citanest, Fortacin, Oraqix, Prilocaine (prilocaine) is a small molecule pharmaceutical. Prilocaine was first approved as Citanest forte on 1982-01-01. It is used to treat pain in the USA. It has been approved in Europe to treat physiological sexual dysfunction and premature ejaculation.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
urogenital diseasesD000091642
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
mental disordersD001523
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
Prilocaine (discontinued: Citanest)
Combinations
Citanest, Lidocaine prilocaine, Oraqix, Prilocaine epinephrine (discontinued: Citanest, Emla, Lidocaine prilocaine)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Lidocaine
+
Prilocaine
Tradename
Company
Number
Date
Products
ORAQIXDentsply PharmaceuticalN-021451 RX2003-12-19
1 products, RLD, RS
Show 2 discontinued
Prilocaine hydrochloride
Tradename
Company
Number
Date
Products
CITANESTAstraZenecaN-014763 DISCN1982-01-01
3 products, RLD
CITANEST PLAINAstraZenecaN-014763 DISCN1982-01-01
1 products, RLD
CITANEST PLAIN DENTALDentsply PharmaceuticalN-021382 DISCN1982-01-01
1 products, RLD
Hide discontinued
Epinephrine bitartrate
+
Prilocaine hydrochloride
Tradename
Company
Number
Date
Products
CITANEST FORTE DENTALDentsply PharmaceuticalN-021383 RX1982-01-01
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
agoneazeunapproved drug other2018-04-18
anodyne lptNDA authorized generic2017-03-17
cadira compliant blood statunapproved drug other2018-11-01
citanest forte dentalANDA2024-02-29
citanest plainANDA2021-11-10
dermacinrx prikaanNDA authorized generic2016-09-19
dibucaine hcl 0.5% / lidocaine 15% / phenylephrine hcl 1% / prilocaine 5%unapproved drug other2019-05-10
inflammation reduction packANDA2015-11-18
lido bdkunapproved drug other2018-11-01
lido-prilo caine packNDA authorized generic2017-01-09
Show 18 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
painEFO_0003843D010146R52
ventricular tachycardia—D017180I47.2
cardiac arrhythmiasEFO_0004269D001145I49.9
burns—D002056T30.0
esophageal diseasesEFO_0009544D004935K22.9
ventricular fibrillationHP_0001663D014693I49.01
ventricular premature complexes—D018879I49.3
mouth diseasesEFO_1001047D009059K13
paroxysmal tachycardiaEFO_0009493D013614I47
septic shock—D012772A48.3
Show 8 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
— N01: Anesthetics
— N01B: Local anesthetics
— N01BB: Amide local anesthetics
— N01BB04: Prilocaine
— N01BB54: Prilocaine, combinations
HCPCS
No data
Clinical
Clinical Trials
258 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R521————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePrilocaine
INNprilocaine
Description
Prilocaine is an amino acid amide in which N-propyl-DL-alanine and 2-methylaniline have combined to form the amide bond; used as a local anaesthetic. It has a role as a local anaesthetic and an anticonvulsant. It is an amino acid amide and a monocarboxylic acid amide.
Classification
Small molecule
Drug classlocal anesthetics
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCCNC(C)C(=O)Nc1ccccc1C
Identifiers
PDB—
CAS-ID721-50-6
RxCUI—
ChEMBL IDCHEMBL1194
ChEBI ID8404
PubChem CID4906
DrugBankDB00750
UNII ID046O35D44R (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Prilocaine
+
Lidocaine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Prilocaine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 4,247 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
917 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use